ATOM rose by 4% on Wednesday after Cosmos executives terminated EVM development to concentrate on blockchain interoperability by advancing its own IBC protocol. The news was met well by investors as ...

Overall, the developers in the study accepted less than 44 percent of the code generated by AI without modification. A ...

Explore how Kimi K2’s trillion-parameter design is democratizing AI, sparking innovation, and challenging commercial AI ...

Imagine a future where artificial intelligence quietly shoulders the drudgery of software development: refactoring tangled ...

The foundation behind Novo Nordisk, which makes weight-loss drugs Ozempic and Wegovy, will invest €80 million ($93 million) ...